Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Detection of survivin 2α gene expression in thyroid nodules.

Kyani K, Babaei E, Feizi MA, Vandghanooni S, Montazeri V, Halimi M.

J Cancer Res Ther. 2014 Apr-Jun;10(2):312-6. doi: 10.4103/0973-1482.136598.

2.

Survivin-deltaEx3: a novel biomarker for diagnosis of papillary thyroid carcinoma.

Vandghanooni S, Eskandani M, Montazeri V, Halimi M, Babaei E, Feizi MA.

J Cancer Res Ther. 2011 Jul-Sep;7(3):325-30. doi: 10.4103/0973-1482.87038.

3.

Expression of survivin and its four splice variants in colorectal cancer and its clinical significances.

Ge QX, Li YY, Nie YQ, Zuo WG, Du YL.

Med Oncol. 2013 Jun;30(2):535. doi: 10.1007/s12032-013-0535-6.

PMID:
23494669
4.

Targeting of the anti-apoptotic gene survivin in human thyroid carcinoma.

Chen Z, Liu N, Zhu G, Dralle H, Hoang-Vu C.

Int J Mol Med. 2012 Sep;30(3):465-72. doi: 10.3892/ijmm.2012.1046.

5.

Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer.

Moniri Javadhesari S, Gharechahi J, Hosseinpour Feizi MA, Montazeri V, Halimi M.

Genet Test Mol Biomarkers. 2013 Apr;17(4):314-20. doi: 10.1089/gtmb.2012.0411.

PMID:
23368531
6.

Survivin delta Ex3 overexpression in thyroid malignancies.

Waligórska-Stachura J, Andrusiewicz M, Sawicka-Gutaj N, Biczysko M, Jankowska A, Kubiczak M, Czarnywojtek A, Wrotkowska E, Ruchała M.

PLoS One. 2014 Jun 19;9(6):e100534. doi: 10.1371/journal.pone.0100534.

7.

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies.

Caldas H, Honsey LE, Altura RA.

Mol Cancer. 2005 Mar 2;4(1):11.

8.

Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.

Ringel MD, Anderson J, Souza SL, Burch HB, Tambascia M, Shriver CD, Tuttle RM.

Mod Pathol. 2001 Apr;14(4):289-96.

9.

Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.

Liou MJ, Chan EC, Lin JD, Liu FH, Chao TC.

Cancer Lett. 2003 Mar 10;191(2):223-7.

PMID:
12618337
10.

Expression of survivin and its splice variants in gastric cancer.

Cheng Z, Hu L, Fu W, Zhang Q, Liao X.

J Huazhong Univ Sci Technolog Med Sci. 2007 Aug;27(4):393-8.

PMID:
17828494
11.

Overview of molecular biomarkers for enhancing the management of cytologically indeterminate thyroid nodules and thyroid cancer.

Duick DS.

Endocr Pract. 2012 Jul-Aug;18(4):611-5. doi: 10.4158/EP12065.RA. Review.

PMID:
22849877
12.

[Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].

Wang LH, Zhao YJ, Wang XY, Yuan P, Xu WQ, Xiao JC, Xu JP, Luo BR.

Zhonghua Zhong Liu Za Zhi. 2005 Sep;27(9):547-50. Chinese.

PMID:
16438854
13.

Survivin and laryngeal carcinoma prognosis: nuclear localization and expression of splice variants.

Marioni G, Agostini M, Bedin C, Blandamura S, Stellini E, Favero G, Lionello M, Giacomelli L, Burti S, D'Angelo E, Nitti D, Staffieri A, De Filippis C.

Histopathology. 2012 Aug;61(2):247-56. doi: 10.1111/j.1365-2559.2012.04217.x.

PMID:
22416874
14.

Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma.

De Maria S, Pannone G, Bufo P, Santoro A, Serpico R, Metafora S, Rubini C, Pasquali D, Papagerakis SM, Staibano S, De Rosa G, Farina E, Emanuelli M, Santarelli A, Mariggiò MA, Lo Russo L, Lo Muzio L.

J Cancer Res Clin Oncol. 2009 Jan;135(1):107-16. doi: 10.1007/s00432-008-0433-z.

PMID:
18642030
15.

Expression and significance of IGF-1 and IGF-1R in thyroid nodules.

Liu YJ, Qiang W, Shi J, Lv SQ, Ji MJ, Shi BY.

Endocrine. 2013 Aug;44(1):158-64. doi: 10.1007/s12020-012-9864-z.

PMID:
23288662
16.

[Detection of malignancy markers in thyroid nodules by reverse transcriptase polymerase chain reaction (RT-PCR)].

Pineda P, Rojas P, Liberman C, Moyano L, Goecke I.

Rev Med Chil. 2003 Sep;131(9):965-72. Spanish.

PMID:
14635582
17.

High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.

Xu C, Yamamoto-Ibusuki M, Yamamoto Y, Yamamoto S, Fujiwara S, Murakami K, Okumura Y, Yamaguchi L, Fujiki Y, Iwase H.

Breast Cancer. 2014 Jul;21(4):482-90. doi: 10.1007/s12282-012-0403-9.

PMID:
22968628
18.

Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma.

Végran F, Boidot R, Bonnetain F, Cadouot M, Chevrier S, Lizard-Nacol S.

Endocr Relat Cancer. 2011 Dec 1;18(6):783-92. doi: 10.1530/ERC-11-0105.

19.

Pendrin expression in nodular and non-nodular thyroid tissues.

Temel B, Gul N, Kutluturk F, Kapran Y, Sirma S, Ustek D, Tunca F, Giles Y, Alagol F.

Endokrynol Pol. 2013;64(3):208-14.

20.

Expression of survivin mRNA in dog tumors.

Uchide T, Takatsu N, Fujimori Y, Fukushima U, Itoh H.

DNA Seq. 2005 Oct;16(5):329-34.

PMID:
16243724
Items per page

Supplemental Content

Support Center